Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Astrazeneca Pharma India Ltd. Share Price
Day's Range
Day's Range
Low
₹6,678.00
High
₹6,769.00
Price Summary
| Previous Close | ₹6,751.50 |
|---|---|
| Day's Range | ₹6,678.00 - ₹6,769.00 |
| Open | ₹6,678.00 |
| 52 Week Range | ₹6,600.00 - ₹9,849.50 |
| Volume | 4,635 |
| Market Cap | ₹0.02 |
| Previous Close | ₹6,751.40 |
|---|---|
| Day's Range | ₹6,610.00 - ₹6,772.65 |
| Open | ₹6,610.00 |
| 52 Week Range | ₹6,610.00 - ₹9,850.00 |
| Volume | 402 |
| Market Cap | ₹0.02 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 312.28 |
|---|---|
| Market Cap (₹ in Mn) | 0.02 |
| Dividend Yield(%) | 0.53 |
| Price/Earning (TTM) | 99.51 |
| TTM EPS (₹) | 67.85 |
| P/E Ratio | 103.45 |
| Book Value(₹) | 18.67 |
| PAT Margin (%) | 8.22 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 31.24 |
| Trade Value ( ₹ in Lacs) | 27.02 |
|---|---|
| Market Cap (₹ in Mn) | 0.02 |
| Dividend Yield(%) | 0.53 |
| Price/Earning (TTM) | 99.51 |
| TTM EPS (₹) | 67.85 |
| P/E Ratio | 103.45 |
| Book Value(₹) | 18.67 |
| PAT Margin (%) | 8.22 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 31.24 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 5263.1 | 17162.9 |
| Expenses | N/A | N/A |
| PBT | 747.0 | 1563.6 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 558.3 | 1157.4 |
About Astrazeneca Pharma India Ltd.
| Founded | 1979 |
|---|---|
| Managing Director | Praveen Rao Akkinepally |
| NSE Symbol | ASTRAZEN |
Latest News
AstraZeneca Pharma India informs about resignation of senior management personnel
AstraZeneca Pharma India informs about press release
In line with Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, AstraZeneca Pharma India has informed that it enclosed the press release for the quarter ended June 30, 2026. The company has informed that the phrase ‘Profit after exceptional item and tax’ appearing in the financial performance summary is to be read as ‘Profit after exceptional item and before tax’ (i.e. Profit before tax).
The above information is a part of company’s filings submitted to BSE.
AstraZeneca Pharma India informs about certificate
AstraZeneca Pharma India informs about resignation of CFO
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III thereto, AstraZeneca Pharma India has informed that, Bhavana Agrawal, Executive Director and Chief Financial Officer (‘CFO’) has communicated her resignation from the position of CFO (Key Managerial Personnel) of the Company with effect from the close of business hours on August 31, 2026, pursuant to her appointment to a regional role within the AstraZeneca Group. A copy of the resignation letter is enclosed as Annexure – A. Further, the details as required under the SEBI Master Circular SEBI/HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as Annexure – B.
The above information is a part of company’s filings submitted to BSE.
Centenial Surgical Suture informs about trading window closure
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Astrazeneca Pharma India Ltd. is ₹6,751.50 as of 2026-09-18.
The market capitalisation of Astrazeneca Pharma India Ltd. is ₹16,878.50 as of 2026-09-18.
The 1-year return of Astrazeneca Pharma India Ltd. is -2,183.00% as of 2026-09-18.
The P/E ratio of Astrazeneca Pharma India Ltd. is 103.45 as of 2026-09-21.
The 52-week high and low of Astrazeneca Pharma India Ltd. are ₹9,849.50 and ₹6,600.00, respectively, as of 2026-09-18.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
